Article
BRAF V600E mutation-specific antibody: A review.
Seminars in diagnostic pathology - 1 Sept 2015
Ritterhouse Lauren L, Barletta Justine A
Abstract excerpt
The significance of BRAF mutations in neoplasia was first recognized in 2002 when mutations were discovered in a broad range of cancers. Numerous subsequent studies expanded our understanding of BRAF V600E as a critical diagnostic, prognostic, and predictive biomarker in many cancers. Additionally, the advent of small-molecule inhibitors of BRAF V600E rendered assessment of BRAF mutation status essential in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
